Answers are grounded in this paper and cite their sources.
Ciprofloxacin is the first-line drug for treating typhoid fever in many countries in Africa with a high disease burden, but the emergence of non-susceptibility poses a challenge to public health programmes. Through enhanced surveillance as part of vaccine evaluation, we investigated the occurrence and potential determinants of ciprofloxacin non-susceptibility in Blantyre, Malawi.
No takes yet. Share an insight, caveat, or question.
Ashton et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: